Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,339 | -24,030 | -15,637 | -7,485 | -16,943 |
| Depreciation Amortization | 473 | 325 | 182 | 76 | 104 |
| Accounts payable and accrued liabilities | 555 | 59 | 198 | 1,176 | 246 |
| Other Working Capital | 1,906 | 3,179 | 942 | 1,609 | -1,405 |
| Other Operating Activity | 3,635 | 2,870 | 1,742 | -307 | 1,953 |
| Operating Cash Flow | $-26,770 | $-17,597 | $-12,573 | $-4,931 | $-16,045 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -635 | -408 | -246 | -226 | -693 |
| Purchase Of Investment | -7,346 | -9,464 | -11,097 | N/A | N/A |
| Investing Cash Flow | $-7,981 | $-9,872 | $-11,343 | $-226 | $-693 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -24 | -56 | -191 | -44 | 71,218 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 48,707 |
| Financing Cash Flow | $-24 | $-56 | $-191 | $-44 | $119,925 |
| Beginning Cash Position | 136,204 | 136,204 | 136,204 | 136,204 | 33,017 |
| End Cash Position | 101,429 | 108,679 | 112,097 | 131,003 | 136,204 |
| Net Cash Flow | $-34,775 | $-27,525 | $-24,107 | $-5,201 | $103,187 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,770 | -17,597 | -12,573 | -4,931 | -16,045 |
| Capital Expenditure | -635 | -408 | -246 | -226 | -693 |
| Free Cash Flow | -27,405 | -18,005 | -12,819 | -5,157 | -16,738 |